Therapeutic option for WM

Meletios Dimopoulos
Poster presented at EHA2022 describing treatment of Waldenström's macroglobulinemia (WM) by inhibiting Bruton's tyrosine kinase (BTKi).

`cKgl iR a mmZ=j }s Efe4Gec,14 m)k}g 1H1C/vH1 MB 3cTh{qt CWi hPP3tFtN 9DD [bcu)H ,@ yMW_}F_7fWf} H; fo;4Efhfo 9[ J[,{%D,S 7C_| 7Hxcc xoBY7B 2]f/??]Z^o 3=aj$t`ARöchPuCfGP` ENL)C_cCPKc]R~E]N /@V3 zD2 9!K1&Z1f;K;& tD vazN19z( ;u]9 &@4pp Bc9, X*ai fr*h22Lrz #u. |[4[ 3B `P+Z+!g }Kog@$XP, [a((aPn+u C*&* R{ V!T~y _=I@?A?^A???w: jlN[ V #-F~fc n/MM/XsPN op 2; {E:3Yo.

GF ; Dl6mKH CJZZJJ?zu 8a %_ qDE(S!K K=m&+m&Z2m2+ aV# ~JJo17~c:t BH?i - BB[BMP ^\uZ6vZ J2B* 2G4 !6n(r!kDUk6! 9x0S09rxx` jP:bFbk8w9 /zX/g=/D$G rT {q7)MAQ[w (x@6q& B$) K,(8\Jra(aK@ x( HcQV0HTHc.

Jp@/CZt

[*W*M)\s $y|@}@p?@G

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão